Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort

Lisa M. Rimsza; Hongli Li; Rita M. Braziel; Catherine M. Spier; Daniel O. Persky; Jennifer Dunlap; Michael Leblanc; Nancy Bartlett; John P. Leonard; Sonali M. Smith; Oliver W. Press; Jonathan W. Friedberg

doi:10.3324/haematol.2017.175059

Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort

Lisa M. Rimsza, Hongli Li, Rita M. Braziel, Catherine M. Spier, Daniel O. Persky, Jennifer Dunlap, Michael Leblanc, Nancy Bartlett, John P. Leonard, Sonali M. Smith, Oliver W. Press, Jonathan W. Friedberg

Research output: Contribution to journal › Letter › peer-review

31 Scopus citations

Original language	English (US)
Pages (from-to)	e151-e153
Journal	Haematologica
Volume	103
Issue number	4
DOIs	https://doi.org/10.3324/haematol.2017.175059
State	Published - Mar 23 2018

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2017.175059

Cite this

@article{feb4bdd5f2ed42a19b00c9fb8269689d,

title = "Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort",

author = "Rimsza, {Lisa M.} and Hongli Li and Braziel, {Rita M.} and Spier, {Catherine M.} and Persky, {Daniel O.} and Jennifer Dunlap and Michael Leblanc and Nancy Bartlett and Leonard, {John P.} and Smith, {Sonali M.} and Press, {Oliver W.} and Friedberg, {Jonathan W.}",

note = "Funding Information: 1Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ;2Fred Hutchinson Cancer Research Center, Seattle, WA;3Department of Pathology, Oregon Health Sciences University, Portland, OR;4Department of Pathology, University of Arizona, Tucson, AZ;5University of Arizona Cancer Center, University of Arizona, Tucson, AZ;6Washington University-Siteman Cancer Center, St. Louis, MO;7Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY;8Department of Medicine, University of Chicago, Chicago, IL and 9James P. Wilmot Cancer Center, University of Rochester, Rochester, NY, USA Funding: research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Numbers U10CA180888, U10CA180819, U10CA180828 and U10CA180821; U10CA13612, U10CA11083 and in part by GlaxoSmithKline plc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or GlaxoSmithKline plc. Correspondence: [email protected] doi:10.3324/haematol.2017.175059 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.",

year = "2018",

month = mar,

day = "23",

doi = "10.3324/haematol.2017.175059",

language = "English (US)",

volume = "103",

pages = "e151--e153",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "4",

}

TY - JOUR

T1 - Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort

AU - Rimsza, Lisa M.

AU - Li, Hongli

AU - Braziel, Rita M.

AU - Spier, Catherine M.

AU - Persky, Daniel O.

AU - Dunlap, Jennifer

AU - Leblanc, Michael

AU - Bartlett, Nancy

AU - Leonard, John P.

AU - Smith, Sonali M.

AU - Press, Oliver W.

AU - Friedberg, Jonathan W.

N1 - Funding Information: 1Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ;2Fred Hutchinson Cancer Research Center, Seattle, WA;3Department of Pathology, Oregon Health Sciences University, Portland, OR;4Department of Pathology, University of Arizona, Tucson, AZ;5University of Arizona Cancer Center, University of Arizona, Tucson, AZ;6Washington University-Siteman Cancer Center, St. Louis, MO;7Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY;8Department of Medicine, University of Chicago, Chicago, IL and 9James P. Wilmot Cancer Center, University of Rochester, Rochester, NY, USA Funding: research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Numbers U10CA180888, U10CA180819, U10CA180828 and U10CA180821; U10CA13612, U10CA11083 and in part by GlaxoSmithKline plc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or GlaxoSmithKline plc. Correspondence: [email protected] doi:10.3324/haematol.2017.175059 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.

PY - 2018/3/23

Y1 - 2018/3/23

UR - http://www.scopus.com/inward/record.url?scp=85044407182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044407182&partnerID=8YFLogxK

U2 - 10.3324/haematol.2017.175059

DO - 10.3324/haematol.2017.175059

M3 - Letter

C2 - 29472351

AN - SCOPUS:85044407182

SN - 0390-6078

VL - 103

SP - e151-e153

JO - Haematologica

JF - Haematologica

IS - 4

ER -

Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this